ClinicalTrials.Veeva

Menu

Postoperative Lactate and Atrial Fibrillation After CABG

B

Başakşehir Çam & Sakura City Hospital

Status

Enrolling

Conditions

Coronary Artery Disease
Atrial Fibrillation

Study type

Observational

Funder types

Other

Identifiers

NCT05448521
KAEK/2021.12.289

Details and patient eligibility

About

Postoperative atrial fibrillation (POAF) is associated with increased mortality and morbidity in patients undergoing isolated coronary artery bypass grafting (CABG). It has been estimated that 5-40% of CABG patients experience POAF. Advanced age, P wave abnormalities, left atrial dilation, emergency surgery, low left ventricle ejection fraction, low glomerular filtration rate and chronic obstructive pulmonary disease have been reported in the etiology. Predicting which patients would experience POAF following CABG is important since it would allow physicians to apply more focused prophylactic measures. Lactate is the final product of anaerobic glycolysis. Serum lactate level are increased in case of inadequate oxygen delivery to tissues. The investigators aim to assess whether serum lactate levels measured early in the postoperative period could be used as a predictive marker of POAF in adults undergoing isolated CABG.

Enrollment

250 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Undergoing isolated CABG
  • Age >18 years

Exclusion criteria

  • Age <18 years
  • Pregnancy
  • History of paroxysmal atrial fibrillation prior to surgery
  • Undergoing concomitant procedures (e.g., CABG + valve surgery)
  • Any preoperative cardiac rhythm other than normal sinus rhythm
  • More than mild cardiac valve stenosis or insufficiency

Trial design

250 participants in 2 patient groups

Low lactate
Description:
Patients with a low lactate level defined by logistic regression analysis.
High lactate
Description:
Patients with a high lactate level defined by logistic regression analysis.

Trial contacts and locations

1

Loading...

Central trial contact

Zeki Temizturk, MD; Ahmet Can Topcu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems